Characteristic | No. of patients (%) |
---|---|
Histology | |
 SCCA | 9 (52.9%) |
 AdenoCa | 6 (35.3%) |
 Small cell | 1 (5.9%) |
 Adenosquamous | 1 (5.9%) |
Grade | |
 Well differentiated | 3 (17.6%) |
 Moderately differentiated | 3 (17.6%) |
 Poorly differentiated | 11 (64.7%) |
Treatment modality | |
 Surgery only | 3 (17.6%) |
 Chemo-RT | 14 (82.4%) |
FIGO stage | |
 IA | 0 (0%) |
 IB1 | 4 (23.5%) |
 IB2 | 7 (41.2%) |
 IIA | 1 (5.9%) |
 IIB | 0 (0%) |
 IIIA | 1 (5.9%) |
 IIIB | 3 (17.6%) |
 IVA | 0 (0%) |
 IVB | 1 (5.9%) |
Nodal involvement | |
 None | 7 (41.2%) |
 Pelvic | 7 (41.2%) |
 Para-aortic | 2 (11.8%) |
 Supraclavicular | 1 (5.9%) |